Skip to main content

Table 2 Levels of gut-derived metabolites in women with PCOS and controls

From: Gut microbiota and gut-derived metabolites are altered and associated with dietary intake in women with polycystic ovary syndrome

Variable

PCOS

(n = 21)

Controls

(n = 14)

P-value a

P-value b

IPA, ng/mL

77.5 ± 35.3

129.5 ± 57.0

0.002

0.022

Fecal SCFA

(n = 22)

(n = 14)

  

Acetic acid, µm/g

159.8 ± 85.5

114.1 ± 88.8

0.133

 

Propionic acid, µm/g

58.7 ± 37.7

36.5 ± 30.7

0.021

0.134

Butyric acid, µm/g

44.8 ± 25.7

26.9 ± 23.8

0.044

0.065

Isobutyric acid, µm/g

5.1 ± 2.1

4.6 ± 1.8

0.490

 

Valeric acid, µm/g

10.0 ± 6.4

7.2 ± 4.2

0.167

 

Isovaleric acid, µm/g

4.6 ± 2.3

4.1 ± 2.0

0.487

 

Caproic acid, µm/g

3.5 ± 3.6

2.3 ± 3.2

0.637

 

Formic acid, µm/g

2.4 ± 2.4

1.8 ± 1.7

0.436

 

Succinic acid, µm/g

10.3 ± 29.5

8.3 ± 26.4

0.296

 

Plasma SCFA

(n = 24)

(n = 14)

  

Acetic acid, µM

76.2 ± 28.2

46.2 ± 20.9

0.001

0.001

Propionic acid, µM

3.9 ± 1.3

2.5 ± 0.7

< 0.001

< 0.001

Butyric acid, µM

0.2 ± 0.1

0.2 ± 0.2

0.470

 

Isobutyric acid, µM

2.6 ± 0.7

2.1 ± 0.5

0.024

0.022

Valeric acid, µM

0.1 ± 0.1

0.2 ± 0.1

0.026

0.044

Isovaleric acid, µM

1.2 ± 0.5

1.1 ± 0.4

0.438

 

Caproic acid, µM c

0.2 ± 0.3

0.2 ± 0.1

0.879

 

Formic acid, µM

146.4 ± 61.1

60.8 ± 17.3

< 0.001

0.842

Succinic acid, µM c

2.4 ± 0.7

2.4 ± 0.6

0.847

 
  1. PCOS, polycystic ovary syndrome; IPA, indole-3-propionic acid; SCFA, short-chain fatty acid
  2. Data are shown as mean ± SD, median (IQR), or % as indicated
  3. a Independent samples t-test
  4. b UNIANOVA adjusted for body mass index
  5. c Log-transformed variables
  6. Statistically significant differences are in bold